It began one evening on a paper napkin. No, really.

After the acquisition of endometrial ablation innovator Novacept in 2004, a team of women’s health veterans couldn’t stop envisioning a better, non-hormonal solution for heavy periods. Then, one night in 2008, they found themselves with a paper napkin, a pen, and their growing passion to end AUB.

“We asked ourselves, if we could do it all over again, what would we do differently? What changes would we make? So we sketched out a new and improved device on a napkin, and that night Minerva Surgical was born. Seven years later Minerva ES was approved by the FDA.”

AUB is a serious problem

In the prime of their lives, with significant personal and professional responsibilities, 1 in 3 women shoulder the additional burden of pain, heavy bleeding, fatigue and depression–just some of the symptoms associated with AUB1.

One-third of outpatient visits to the gynecologist are for AUB, and AUB accounts for more than 70% of all gynecologic consults in the perimenopausal and post-menopausal years2. This common condition often results in a hysterectomy due to benign causes if not treated.

Under-treated, under-reported and normalized

“Since launching Minerva ES in 2015, we’ve learned a lot about the impact AUB has on women and their daily lives. Hearing first hand how women suffer with fibroids, polyps and heavy periods moved us to double down.”

“In 2020 we acquired three additional devices for the treatment of AUB, creating a complete, best-in-class intrauterine care kit. Now we can make swift progress toward our goal of providing device-enabled solutions for AUB that are uterus-sparing, minimally invasive, safe and effective.”

“By treating the root causes of AUB, physicians give women the best chance of avoiding a hysterectomy.”

The survey

In an international online survey study of 6,179 women aged 18–55

36%

had either been diagnosed with heavy menstrual bleeding (HMB) or thought their menstruation was heavier than average, a common symptom of AUB2.

41%

of these women believed there were no treatment options available for them2.

Uterine fibroids

are cited as the most common indication for hysterectomy, accounting for approximately one-third of all hysterectomies performed3.

Abnormal uterine bleeding

is the next most common indication, accounting for approximately 16% of hysterectomies, while gynecologic cancers account for less than 8% of all hysterectomies3.

Hysterectomy

is the second most common surgery performed on reproductive-age women in the U.S., after cesarean section. More than 400,000 hysterectomies are performed in the U.S. each year with nearly 68 percent done for benign conditions that involve abnormal uterine bleeding, uterine fibroids and endometriosis4.

“When someone asks me about what we do here, inevitably they mention a person they know who has suffered because of their period. Every month, all year long, they pay the price in many ways. We can do something about it and provide women with effective alternatives to hysterectomies.”

“We can do a better job of prioritizing women’s experience with their periods. By reducing the incidence of AUB through awareness and treatment, women will be free of debilitating symptoms and significantly improve their quality of life. They and their families and communities will benefit. We all benefit.

That’s our motivation.”

Dave Clapper, President & CEO,
Minerva Surgical

It takes a team to end AUB

We are in continuous pursuit of excellence: in engineering, in customer support, and out in the field where our team serves as an extension of yours. Meet some of the people who bring years of experience in women’s healthcare to work each day, but it’s their passion for ending AUB that drives Minerva forward.

Sharon, Customer Service
“It feels good to work for a company that is purpose driven. I have been a part of the Minerva team for over a decade. It has always been our mission to act in good faith, to have integrity in our products, in how we treat each other, our customers and ultimately the countless women we serve.”

– Sharon

 

 

 

Dave, President & CEO
“It’s rewarding working with great people who make great products that alleviate AUB and avoid unnecessary hysterectomies. What an honor to serve our mothers, sisters, wives and neighbors!”

– Dave

 

 

 

Philip, Quality Assurance
“I am excited to be part of a dynamic and innovative company, advancing women’s health and well-being one product at a time!”

– Philip

 

 

 

Tejas, Research & Development
“Minerva exemplifies quality and care.  Patient and physician satisfaction are of paramount importance to us.”

– Tejas

 

 

 

Israel, Materials Management
“Working at Minerva gives me the opportunity to see my contributions make a difference in the overall goal of the company: support women in need who suffer with AUB.”’

– Israel

 

 

 

Kaye, Human Resources
“It is an honor to work at Minerva, alongside a great group of people who strive daily to help women have a better quality of life. This inspires and motivates me.”

– Kaye

 

 

 

Dom, Research & Development
“Having spent my entire career in med tech start-ups, I’ve enjoyed developing innovative products that really move the needle for so many people. I love that at Minerva, we marry advanced technology with creative solutions to make great products exclusively for women.”

– Dom

 

 

 

Thad, Customer Service
“At Minerva our customers come first. That makes my work in customer service all the more worthwhile and enjoyable.”

– Thad

 

 

 

Klyde, Operations
“Work is a large part of my life and the only way to be satisfied is to do great work. And the only way to do great work is to love what you do. I have the ability to perform great work at Minerva.”

– Klyde

 

 

 

Joel, Finance
“I’m honored to be working with such a talented team focused on improving women’s lives.”

– Joel

 

 

 

 

Remembering
Brian Ahmann
1980-2020
“We are mourning the recent loss of Brian Ahmann, our beloved friend and co-worker. Brian was our Director of Marketing and a long-time member of the Minerva Surgical family. He made an immeasurable impact on the company over the last 10 years. He will long be remembered for his unparalleled work ethic, his positive attitude, and his team spirit.

He was a kind and generous soul, always the first to smile, the first to toast and celebrate each success, and first to support those in need. He will also be remembered for how much he loved his parents and brother.

Rest In Peace, Brian. You are forever loved.”

 

We’re just getting started

There’s never been a better time to join Minerva Surgical. Learn more about what it’s like to work here, view our open positions and get in touch with us.

No layers. No hoops. No upcharges. Just responsive support for your team.

1. https://www.acog.org/womens-health/faqs/heavy-menstrual-bleeding
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291434/
3. Stewart EA, Shuster LT, Rocca WA. Reassessing hysterectomy. Minn Med. 2012;95(3):36-39.
4. Plotting the Downward Trend in Traditional Hysterectomy
5. Laughlin-Tommaso SK, et al. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause. 2018 May;25(5):483-492. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898981/pdf/nihms918518.pdf